Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
By Christian Confavreux, Sandra Vukusic, P. Adeleine. Brain : a journal of neurology, 2003
1,023 citations recorded by the source corpus.
Subfields: Hematology, Pathology and Forensic Medicine, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/1664d613377060ff2a7a7aa0c239d9ca24e43891
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Hematology
In Pathology and Forensic Medicine
- Hans Lassmann
- Wolfgang Brück
- C. Lucchinetti
- Stephen L. Hauser
- Sandra Vukusic
- Christian Confavreux
- Jorge R. Oksenberg
In Psychiatry and Mental health
Citations in the corpus
- The epidemiology of multiple sclerosis in Europe (2006, methodology): “As for the disease course, based on EDMUS, 58% of cases were RR-MS, 27% were SP-MS and 15% PP-MS [82].”
- The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. (2006, background): “In contrast, no other variables, including relapsing or progressive course, substantially affected the time to reach severe disability (Confavreux et al., 2003; Confavreux and Vukusic, 2006b).”
- Cortical demyelination and diffuse white matter injury in multiple sclerosis. (2005, background): “…in the early phase of the disease influences the time of onset of progression, however once a threshold of disability is reached, progression of disability is not affected by relapses either before or after the onset of the progressive phase (Confavreux et al., 2003; Pittock et al., 2004).”
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. (2008, background): “Optic neuritis presentation has been associated with better outcome in several reports (Beck et al., 2003, 2004; Confavreux et al., 2003; Nilsson et al., 2005) and nearly half of our cohort presented with optic neuritis.”
- Natural history of multiple sclerosis: a unifying concept. (2006, methodology): “Interestingly, the ‘amnesic phenomenon’ is observed wherever the detectable threshold for irreversible disability is set (Confavreux et al., 2003; Coustans et al., 2004), and whether or not the phase of relapses and remissions has passed (Fog and Linnemann, 1970; Patzold and Pocklington, 1982) and l”